These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 11798601

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
    Elder DJ, Halton DE, Crew TE, Paraskeva C.
    Int J Cancer; 2000 May 15; 86(4):553-60. PubMed ID: 10797271
    [Abstract] [Full Text] [Related]

  • 3. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.
    Tanaka S, Tatsuguchi A, Futagami S, Gudis K, Wada K, Seo T, Mitsui K, Yonezawa M, Nagata K, Fujimori S, Tsukui T, Kishida T, Sakamoto C.
    Gut; 2006 Jan 15; 55(1):54-61. PubMed ID: 16085694
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells.
    Zhang ZH, Ouyang Q, Gan HT.
    World J Gastroenterol; 2004 Oct 15; 10(20):2954-7. PubMed ID: 15378772
    [Abstract] [Full Text] [Related]

  • 6. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M.
    Int J Oncol; 2003 Apr 15; 22(4):757-63. PubMed ID: 12632065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells.
    Onoda T, Ono T, Dhar DK, Yamanoi A, Fujii T, Nagasue N.
    J Lab Clin Med; 2004 Apr 15; 143(4):207-16. PubMed ID: 15085079
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR.
    Mol Carcinog; 2007 Dec 15; 46(12):971-80. PubMed ID: 17477358
    [Abstract] [Full Text] [Related]

  • 11. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells.
    Smartt HJ, Elder DJ, Hicks DJ, Williams NA, Paraskeva C.
    Br J Cancer; 2003 Oct 06; 89(7):1358-65. PubMed ID: 14520472
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ, Halton DE, Hague A, Paraskeva C.
    Clin Cancer Res; 1997 Oct 06; 3(10):1679-83. PubMed ID: 9815550
    [Abstract] [Full Text] [Related]

  • 13. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM.
    J Am Coll Surg; 2004 Sep 06; 199(3):428-35. PubMed ID: 15325613
    [Abstract] [Full Text] [Related]

  • 14. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC, McBride WH, Chen SM, Lee KF, Hwang TZ, Jung SM, Shau H, Liao SK, Hong JH, Chen MF.
    Head Neck; 2005 Jun 06; 27(6):503-12. PubMed ID: 15772955
    [Abstract] [Full Text] [Related]

  • 15. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM.
    Cancer Res; 2000 Sep 01; 60(17):4926-31. PubMed ID: 10987308
    [Abstract] [Full Text] [Related]

  • 16. NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation.
    Smakman N, Schaap N, Snijckers CM, Borel Rinkes IH, Kranenburg O.
    Urology; 2005 Aug 01; 66(2):434-40. PubMed ID: 16098373
    [Abstract] [Full Text] [Related]

  • 17. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS.
    Clin Cancer Res; 2001 May 01; 7(5):1410-8. PubMed ID: 11350912
    [Abstract] [Full Text] [Related]

  • 18. [The role and mechanisms of cyclooxygenase-2 inhibitors on the proliferation of hepatic stellate cell].
    HE YJ, PAN J, SHU JC, SHEN Y, LV X, FANG L.
    Zhonghua Gan Zang Bing Za Zhi; 2009 May 01; 17(5):346-9. PubMed ID: 19497199
    [Abstract] [Full Text] [Related]

  • 19. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ.
    Int J Oncol; 2003 Jul 01; 23(1):113-9. PubMed ID: 12792783
    [Abstract] [Full Text] [Related]

  • 20. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
    Duan DP, Dang XQ, Wang KZ, Wang YP, Zhang H, You WL.
    Oncol Rep; 2012 Nov 01; 28(5):1693-700. PubMed ID: 22922684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.